Cloud platform solution for easy and accurate quantitative assessment of brain images and for providing clinical decision support in neurological disorders.

Get support to manage the bulk of post COVID 19 patients being evaluated for dementia or Multiple Sclerosis

Up to 4 releases per Year

With cNeuro® you will be able to focus on essential information and automatically obtain a report that enables early diagnosis and efficient management of neurodegenerative diseases

Cloud

computing

Machine

learning

Web-

based

Patient

privacy

Collaborative Solution

cNeuro® cMRI 
Quantitative MRI for radiologists

  • Fully automated cross-sectional and longitudinal analysis of atrophy and lesions with seamless PACS integration.
  • Enhance your workflow and provide detailed report to referring physician.

cNeuro® cDSI 
 Advanced Solution for neurologists

  • Combines imaging findings with other data such as CSF-biomarkers and neuropsychology tests results and compares to a large database of previously diagnosed cases. 
  • Get support to detect disease early, perform differential diagnostics, predict progression and decide whether more testing is needed.

FOR MORE INFORMATION  
Please contact us at
Email: michel@combinostics.com
Phone: +32 497 319565 

OUR OFFICE
Combinostics Oy
Hatanpään valtatie 24
33100 Tampere, FINLAND

Go to article: Home | How safe is your health data?Go to article: In This IssueGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: ContentsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: NewsGo to article: GS SwissGo to article: Proportion AirGo to article: The medical industry briefingGo to article: Neuralink could pave way to new world of neural implantsGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: The global orthopaedics market is gradually recovering from the Covid-19 pandemiGo to article: CombinosticsGo to article: Tricor SystemsGo to article: Covid-19 pandemic may give wearables necessary push to become healthcare mainstaysGo to article: NIH awards contracts for innovative digital solutions for the Covid-19 pandemicGo to article: PSN LabsGo to article: Ischemic stroke market will likely experience limited impact despite second waveGo to article: Cambridge Polymer GroupGo to article: Mental health data: it’s not so private after allGo to article: CorTec Go to article: Marshall ManufacturingGo to article: Jaws of life: robot tests potential of medicated gumGo to article: device25Go to article: Peak Performance Compounding Go to article: Wearable wonderland: how tech is tackling Covid-19Go to article: INDO-MIMGo to article: Fibroids treatment without the fussGo to article: uvexGo to article: Catching cancer: could a new blood test rewrite oncology?Go to article: KSP Go to article: How technology is giving ICU patients a voiceGo to article: ICF MercantileGo to article: Will Covid-19 bring a return to single-use medical devices?Go to article: KUK ElectronicGo to article: Covid-19: how medtech is adapting to a distanced worldGo to article: Repsol Go to article: The key list powered by GlobalDataGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: Deals in brief powered by GlobalDataGo to article: Review Display SystemsGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2 ) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: Baumeier Go to article: LemoGo to article: EventsGo to article: SartoriusGo to article: Next Issue